Deregulation of the Rb and p53 pathways in uveal melanoma

被引:85
作者
Brantley, MA
Harbour, JW
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Div Mol Oncol, St Louis, MO 63110 USA
关键词
D O I
10.1016/S0002-9440(10)64817-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Uveal melanoma is the most common primary eye cancer, yet its molecular pathogenesis is poorly understood. In this study, we investigated the immunohistochemical expression of proteins in the Rb and p53 tumor suppressor pathways in 33 uveal melanomas from enucleated eyes. Strong nuclear staining for Rb was present in most tumors. However, a few cases displayed weak nuclear staining and strong cytoplasmic staining (possibly indicating Rb mutation), and this aberrant staining correlated strongly with failed radiotherapy or thermotherapy before enucleation. Staining for cyclin D1 was positive in most tumors and was associated with advanced age and larger tumor size, which are both poor prognostic factors. Generally, immunostaining for p53 was weak (suggesting a lack of p53 mutations), although p53 positivity correlated strongly with staining for phosphorylated Rb, supporting the notion that inappropriate phosphorylation of Rb can induce p53, Strong immunostaining for MDM2, which can functionally block p53 activity, was observed in most tumors and correlated significantly with female sex. Strong cytoplasmic staining was observed for Bc12, which can inhibit both p53-dependent and -independent apoptosis, We conclude that Rb and p53 are mutated infrequently in uveal melanoma, but their respective pathways may be functionally inactivated.
引用
收藏
页码:1795 / 1801
页数:7
相关论文
共 46 条
  • [1] The retinoblastoma protein pathway in cell cycle control and cancer
    Bartek, J
    Bartkova, J
    Lukas, J
    [J]. EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) : 1 - 6
  • [2] The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death
    Basu, A
    Haldar, S
    [J]. MOLECULAR HUMAN REPRODUCTION, 1998, 4 (12) : 1099 - 1109
  • [3] BOITNOTT J K, 1981, Hepatology, V1, P599, DOI 10.1002/hep.1840010607
  • [4] Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
    Bouchard, C
    Thieke, K
    Maier, A
    Saffrich, R
    Hanley-Hyde, J
    Ansorge, W
    Reed, S
    Sicinski, P
    Bartek, J
    Eilers, M
    [J]. EMBO JOURNAL, 1999, 18 (19) : 5321 - 5333
  • [5] Brantey MA, 2000, CANCER RES, V60, P4320
  • [6] The prognostic significance of c-myc oncogene expression in uveal melanoma
    Chana, JS
    Cree, IA
    Foss, AJE
    Hungerford, JL
    Wilson, GD
    [J]. MELANOMA RESEARCH, 1998, 8 (02) : 139 - 144
  • [7] c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
    Chana, JS
    Wilson, GD
    Cree, IA
    Alexander, RA
    Myatt, N
    Neale, M
    Foss, AJE
    Hungerford, JL
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (01) : 110 - 114
  • [8] Malignant melanoma: modern black plague and genetic black box
    Chin, L
    Merlino, G
    DePinho, RA
    [J]. GENES & DEVELOPMENT, 1998, 12 (22) : 3467 - 3481
  • [9] Coupland SE, 2000, J PATHOL, V191, P120
  • [10] Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma
    Coupland, SE
    Bechrakis, N
    Schüler, A
    Anagnostopoulos, I
    Hummel, M
    Bornfeld, N
    Stein, H
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (08) : 961 - 970